Emory University
Otolaryngology residency · Atlanta, GA · Program website
- 1
- Faculty
- 23
- Trainees
- 140
- Papers
- 52%
- Trainees published
- 23%
- First author
5 people are awaiting a match decision, so numbers may change.
Papers
By this program's faculty and trainees since 2022, 140 in all. Updated 2026-11-07.
- Assessment of Educational Components of a Short‐Term Surgical Trip Partnership: Feasibility and Preliminary OutcomesAlicia B. Yang et al. · OTO Open · 2026 · PubMed
- Blueberry Extract Has Anti‐Proliferative Activity in Preclinical Models of Head and Neck CancerBrendan L. C. Kinney et al. · Head & Neck · 2026 · PubMed
- Progress and Prospects in Otorhinolaryngology—Head and Neck Surgery in EthiopiaDaniel G. Eyassu et al. · World Journal of Otorhinolaryngology - Head and Neck Surgery · 2026 · PubMed
- Thyroid-Presenting Plasmablastic Lymphoma Mimicking Anaplastic Thyroid CarcinomaDavid Z. Allen et al. · Journal of Otorhinolaryngology Hearing and Balance Medicine · 2026
- Preoperative frailty and tumor volume as determinants of primary management strategy and outcomes in petroclival meningioma patientsRommi Kashlan et al. · Frontiers in Surgery · 2026 · PubMed
- Perioperative predictors of biochemical remission in acromegaly: a predictive modeling studyHanyao Sun et al. · Pituitary · 2026 · PubMed
- Making Sense of the 2022 USP 797 UpdateKathryn M. Hardin et al. · Current Otorhinolaryngology Reports · 2026
- De-Escalated Adjuvant Radiation Therapy in Patients With HPV-Positive Oropharyngeal CancerCecelia M. Hidalgo et al. · JAMA Network Open · 2026 · PubMed · cited 2
- Identifying and Mitigating Risk Factors for Last Minute Otolaryngology Surgical CancelationsLauren Linquest et al. · Annals of Otology Rhinology & Laryngology · 2026 · PubMed
- Oncologic Outcomes of HPV(+)OPSCC Patients Treated with De-escalated Adjuvant Radiation to 30-36 Gy vs. Standard of Care: Updated Pooled Analysis of On- and Off-Trial PatientsL.X. Yin et al. · International Journal of Radiation Oncology*Biology*Physics · 2026
How trainees publishauthor positions, faculty co-authorship, ranks
Papers by current residents and fellows, and alumni within two years, published during training. Based on 12 of 23 trainees matched to publication records. Trainees with no match count as not yet published, so these figures are a floor.
Faculty detailsh-index, papers and author positions per person
Program leadership from the program's own pages, matched to publications. Leadership is mostly clinician-educators, so these numbers describe the teaching team, not the department's research. Works since 2022-01-01.
| Name | Research topics | h (lifetime) | Works | 1st | Last | Median FWCI |
|---|---|---|---|---|---|---|
| Anita Sethna, MD FACS | Social Media in Health Education; Reconstructive Facial Surgery Techniques | 4 | 5 | 0 | 1 | 0.69 |
23 trainees are counted above but never listed by name.
About Emory Universityinstitution-wide otolaryngology research
Otolaryngology publications from Emory University and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
Works per year · * 2026 so far
Otolaryngology research topics at Emory University
Papers in the window; each links to the list on OpenAlex.
Most cited at Emory University since 2024
All otolaryngology papers there on OpenAlex
- Interim Futility Results of NRG-HN005, A Randomized, Phase II/III Non-Inferiority Trial for Non-Smoking p16+ Oropharyngeal Cancer PatientsSue Sun Yom et al. · International Journal of Radiation Oncology*Biology*Physics · 2024 · cited 80
- Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre, parallel-group, randomised, phase 2/3 trialLoren K. Mell et al. · The Lancet Oncology · 2024 · PubMed · cited 70
- Transoral Robotic Surgery in the Multidisciplinary Care of Patients With Oropharyngeal Squamous Cell Carcinoma: ASCO GuidelineF. Christopher Holsinger et al. · Journal of Clinical Oncology · 2025 · PubMed · cited 68
- Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and NeckRobert I. Haddad et al. · JAMA · 2025 · PubMed · cited 60
- Biomarkers in head and neck squamous cell carcinoma: unraveling the path to precision immunotherapyKamal S. Saini et al. · Frontiers in Oncology · 2024 · PubMed · cited 32
- Efficacy of EDS-FLU for Chronic Rhinosinusitis: Two Randomized Controlled Trials (ReOpen1 and ReOpen2)James N. Palmer et al. · The Journal of Allergy and Clinical Immunology In Practice · 2024 · PubMed · cited 29
- Long-Term Follow-Up of E3311, an ECOG-ACRIN Cancer Research Group Phase II Trial of Transoral Surgery and Risk-Based Adjuvant Treatment in Human Papillomavirus–Initiated Oropharynx CancerBarbara Ann Burtness et al. · Journal of Clinical Oncology · 2025 · PubMed · cited 28
- Derivation and validation of the AJCC9V pathological stage classification for HPV-positive oropharyngeal carcinoma: a multicentre registry analysisAllen S. Ho et al. · The Lancet Oncology · 2025 · PubMed · cited 24
- Current Review of Comorbidities in Chronic RhinosinusitisAlexander M. Choi et al. · Current Allergy and Asthma Reports · 2024 · PubMed · cited 23
- Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell CarcinomaNabil F. Saba et al. · JAMA Oncology · 2024 · PubMed · cited 23